NET PROFIT (x1000 SEK)
EMPLOYEES
Biocrine AB
Closing information (x1000 SEK)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
0
|
0
|
0 |
| Financial expenses |
54
|
4
|
36 |
| Earnings before taxes |
-9,100
|
-9,803
|
-7,449 |
| EBITDA |
-9,080
|
-9,863
|
-7,421 |
| Total assets |
14,145
|
13,295
|
21,103 |
| Current assets |
1,742
|
427
|
9,524 |
| Current liabilities |
1,375
|
3,629
|
1,634 |
| Equity capital |
12,770
|
9,666
|
19,469 |
| - share capital |
297
|
285
|
271 |
| Employees (average) |
8
|
8
|
8 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
90.3%
|
72.7%
|
92.3% |
| Turnover per employee |
0
|
0
|
0 |
| Profit as a percentage of turnover | |||
| Return on assets (ROA) |
-64.0%
|
-73.7%
|
-35.1% |
| Current ratio |
126.7%
|
11.8%
|
582.9% |
| Return on equity (ROE) |
-71.3%
|
-101.4%
|
-38.3% |
| Change turnover |
0
|
0
|
0 |
| Change turnover % | |||
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.